As London hosts DSEI UK, one of the world’s largest defence trade shows, a look at how the patent system deals with matters of national security Each year, a very small number of patent… read more…
As explored in “The Line Between Beauty and Science I: Patent Strategies for Biotherapeutic Cosmetics”, in the field of bio-cosmetics, “use” claims are a valuable tool for protecting… read more…
An interview with Mathys & Squire Partner Stephen Garner was recently featured in ‘The flaw that landed Sanofi a win in the rare disease space’ by Life Sciences Intellectual Property Review He… read more…
Following the release of her album ‘The Life of a Showgirl’, Taylor continues to demonstrate that intellectual property (IP) is not just a legal asset, it’s a keystone of brand power and control… read more…
In the rapidly evolving world of cosmetics, biotherapeutic molecules, which were once confined to medical and pharmaceutical settings, are now making their way into skincare products, reshaping the… read more…
On 15th July 2025, the UK Government released a consultation on SEPs (Standard Essential Patents) With the aim of facilitating innovation for UK businesses in the digital technology industry, the… read more…
Mathys & Squire is delighted that Partners Sean Leach, Anna Gregson, Dani Kramer and Martin MacLean have all been identified in the 2025 edition of IAM Strategy 300: The World’s Leading IP… read more…
Ultra-processed foods (UPFs) are firmly integrated within modern diets, with factors such as convenience, store availability, cost, food waste and time impacting consumer purchase decisions However,… read more…
Investment Surges in AI-Driven Drug Discovery Artificial intelligence (AI) has emerged as one of the most transformative technologies in recent years The European Medtech sector saw a surge in… read more…